This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Drug Conjugates
August 16-17, 2023
Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST
Menu
Key Sessions
Yelena Kovtun
Panel Discussion: ADC Design and Development from the Biotech Perspective
ex-ImmunoGen, USA
Emily Wyent
Next Generation Targeted High-Capacity Drug Conjugates for Higher Drug-to-Antibody Ratio
Dantari, USA
keyboard_arrow_right

Antibody Drug Conjugates - EST/EDT (Eastern Daylight, GMT-4)

keyboard_arrow_leftSearch & Filter
search

Antibody Drug Conjugates - EST/EDT (Eastern Daylight, GMT-4)

search
Showing 1 of 1 Streams
08:00 - 08:05
Welcoming Remarks
  • Lottie Leinfellner - Digital Events Conference Producer, Informa Connect, UK
08:05 - 08:50
Panel Discussion: ADC Design and Development from the Biotech Perspective
  • Yelena Kovtun - Biotechnology Consultant, ex-ImmunoGen, USA
  • Ben Ayers - Vice President, Antibody-Drug Conjugates, Hummingbird Bioscience, Singapore
  • Philipp Spycher - CEO & Co-Founder, Araris Biotech AG, Switzerland
  • James Italia - VP of Commercial Development, BrickBio, USA
08:50 - 09:20
Cellular Endosomal Processes Guide Nucleus-Targeted ADC Development
  • Jeffrey V. Leyton - Associate Professor, University of Ottowa, Canada
09:20 - 09:50
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability
  • Melissa Schutten - Senior Director, Pathology, Seagen, USA
09:50 - 10:50
Coffee Break & Networking Opportunities on the ConnectMe Platform
10:50 - 11:20
Characterization of Antibody Drug Conjugate Charge Variants by icIEF Fractionation
  • Eunju Jang - Senior Scientist, AbbVie, USA
11:20 - 11:50
Bioanalytical Challenges and Strategies for ADCs Conjugated with Prodrug-Payloads
  • Yihan Li - Senior Scientist, AbbVie, USA
11:50 - 12:20
Next Generation Targeted High-Capacity Drug Conjugates for Higher Drug-to-Antibody Ratio
  • Emily Wyent - Senior Director, Dantari, USA
Antibody Drug Conjugates
Filter
Topics
Choose Day